Radiation Therapy News and Research

RSS

Radiation therapy (also called radiotherapy, x-ray therapy, or irradiation) is the use of a certain type of energy (called ionizing radiation) to kill cancer cells and shrink tumors. Radiation therapy injures or destroys cells in the area being treated (the “target tissue”) by damaging their genetic material, making it impossible for these cells to continue to grow and divide. Although radiation damages both cancer cells and normal cells, most normal cells can recover from the effects of radiation and function properly. The goal of radiation therapy is to damage as many cancer cells as possible, while limiting harm to nearby healthy tissue.

Elekta to highlight Leksell Gamma Knife Perfexion radiosurgery solution at AANS 2011

At the 2011 American Association of Neurological Surgeons (AANS) Annual Meeting, April 9-13 at the Colorado Convention Center, Elekta (booth #1717) will highlight characteristics of Leksell Gamma Knife® Perfexion™ that separate the system from other radiosurgery solutions.

From Elekta 8 Apr 2011

BSD Medical second quarter net loss decreases 19% to $1,554,000

BSD Medical Corporation, a leading provider of medical systems that treat cancer and benign diseases using heat therapy, today reported financial results for its second fiscal quarter ended February 28, 2011.

8 Apr 2011

Persistent fatigue in breast cancer survivors may be caused by autonomic nervous system running in overdrive

The persistent fatigue that plagues one out of every three breast cancer survivors may be caused by one part of the autonomic nervous system running in overdrive, while the other part fails to slow it down.

7 Apr 2011

Living human taste cells maintained in culture for seven months

Following years of futile attempts, new research from the Monell Center demonstrates that living human taste cells can be maintained in culture for at least seven months. The findings provide scientists with a valuable tool to learn about the human sense of taste and how it functions in health and disease.

7 Apr 2011

OncoGenex presents OGX-427 preclinical data in prostrate cancer at AACR meeting

OncoGenex Pharmaceuticals, Inc. announced today that preclinical data utilizing their pipeline compound OGX-427 was presented at the AACR 102nd Annual Meeting 2011.

5 Apr 2011

Synta presents ganetespib and elesclomol study data in cancer at AACR meeting

Synta Pharmaceuticals Corp. today presented five posters at the American Association for Cancer Research 102nd Annual Meeting. Three posters reported results from studies of ganetespib, and two posters reported results from studies of elesclomol, a small-molecule mitochondria metabolism inhibitor.

5 Apr 2011

Oncology experts educate lawmakers about latest information on radiation therapy

Leaders from the radiation oncology community – representing patients, physicians, providers, and manufacturers – met on Capitol Hill today to educate lawmakers and their staffs about the latest in radiation therapy technologies and techniques, improvements in patient care and the community's focus on patient safety in radiation therapy delivery.

1 Apr 2011

TNM 7 system can predict lung cancer recurrence after surgery

The new TNM 7 lung cancer staging system seems to be a better predictor of local or regional recurrence of lung cancer following surgery, according to a study published in the April issue of the Journal of Thoracic Oncology.

1 Apr 2011

Study finds Gamma Knife procedure effective for brain metastases treatment

The volume of normal brain tissue exposed to radiation during treatment for multiple metastases appears to depend on which stereotactic radiosurgery system is employed, according to a recent study in the Journal of Neurosurgery.

31 Mar 2011

Radiation oncologists head to Capitol Hill to promote critical initiatives

More than 100 radiation oncology treatment team members and resident physicians convened in Washington Monday and Tuesday to represent radiation oncology on Capitol Hill at the American Society for Radiation Oncology's (ASTRO) eighth annual Advocacy Day. Participants spent Monday hearing from members of Congress and key congressional staff on the latest legislative activity and ASTRO'’s legislative agenda. On Tuesday, the group headed to House and Senate office buildings to meet with senators, congressmen and staffers from their home states to promote agenda items important to the safety and well-being of cancer patients.

30 Mar 2011

Carl Zeiss Meditec’s MEL 80 Excimer Laser receives PMA from FDA to treat hyperopia

Carl Zeiss Meditec, Inc. announced today that the MEL 80 Excimer Laser has received premarket approval from the U.S. Food and Drug Administration for the treatment of hyperopia.

29 Mar 2011

Science Magazine reports on recent push to make preventing, treating cancer a global priority

Science Magazine reports on the recent push to make preventing and treating cancer a global priority, particularly in developing countries, where it's estimated "less than 5% of the world's cancer resources are spent."

28 Mar 2011

Scientists identify protein that plays a key role in cancer treatment resistance

Research led by Daitoku Sakamuro, PhD, Assistant Professor of Pathology at LSU Health Sciences Center New Orleans and the LSUHSC Stanley S. Scott Cancer Center, has identified a protein that enables the activation of a DNA-repair enzyme that protects cancer cells from catastrophic damage caused by chemo and radiation therapy.

25 Mar 2011

Jefferson Hospitals uses VMAT and Monte Carlo technology for accurate and fast radiation therapy

The Radiation Oncology Department at Thomas Jefferson University Hospitals is now treating cancer patients using a state-of-the-art VMAT technology based on the most accurate dose calculation algorithm that dramatically shortens treatment delivery time.

25 Mar 2011

Resveratrol can provide resistance before and after hazardous radiation exposure

Clinical studies of Resveratrol--recognized for its proven role in activating the longevity gene to inhibit age-related diseases--have shown that its antioxidant power provides resistance before and after exposure to hazardous radiation.

24 Mar 2011

Statins improve outcomes in high-risk prostate cancer patients treated with definitive radiation therapy

Men with high-risk prostate cancer who take statin drugs commonly used to lower cholesterol while receiving radiation therapy are less likely to have their cancer return than patients who do not take these medications, according to a study published in the March issue of the International Journal of Radiation Oncology-Biology-Physics, an official journal of the American Society for Radiation Oncology (ASTRO).

24 Mar 2011

John Muir Health provides new cancer treatment using Varian's RapidArc radiation therapy

John Muir Health is offering a new cancer treatment option using the latest technology from Varian Medical Systems - The Trilogy Linear Accelerator with RapidArc Technology. The new accelerator, located at John Muir Medical Center, Concord, significantly shortens treatment sessions from 15-20 minutes to 2-5 minutes, while improving the precision of the radiotherapy.

24 Mar 2011

NephRx receives new U.S. patent for NX002 to treat oral mucositis

NephRx Corporation today announced issuance of a new U.S. patent for its novel peptide NX002, which currently is in preclinical development for the treatment of oral mucositis.

23 Mar 2011

MnSOD oral drug can protect against lung cancer radiation therapy

Patients with advanced non-small cell lung cancer can safely take an experimental oral drug intended to protect healthy tissue from the effects of radiation, according to a study led by researchers at the University of Pittsburgh Cancer Institute and published in this month's issue of Human Gene Therapy.

23 Mar 2011

SCCA, ProCure to open new proton therapy center for cancer treatment

Seattle Cancer Care Alliance, together with ProCure Treatment Centers Inc., today held its ceremonial groundbreaking on a new proton therapy center in north Seattle that will provide a first-of-its-kind treatment option for cancer patients throughout the Northwest.

23 Mar 2011

Radiation Therapy News and Research

Further Reading

Elekta to highlight Leksell Gamma Knife Perfexion radiosurgery solution at AANS 2011

BSD Medical second quarter net loss decreases 19% to $1,554,000

Persistent fatigue in breast cancer survivors may be caused by autonomic nervous system running in overdrive

Living human taste cells maintained in culture for seven months

OncoGenex presents OGX-427 preclinical data in prostrate cancer at AACR meeting

Synta presents ganetespib and elesclomol study data in cancer at AACR meeting

Oncology experts educate lawmakers about latest information on radiation therapy

TNM 7 system can predict lung cancer recurrence after surgery

Study finds Gamma Knife procedure effective for brain metastases treatment

Radiation oncologists head to Capitol Hill to promote critical initiatives

Carl Zeiss Meditec’s MEL 80 Excimer Laser receives PMA from FDA to treat hyperopia

Science Magazine reports on recent push to make preventing, treating cancer a global priority

Scientists identify protein that plays a key role in cancer treatment resistance

Jefferson Hospitals uses VMAT and Monte Carlo technology for accurate and fast radiation therapy

Resveratrol can provide resistance before and after hazardous radiation exposure

Statins improve outcomes in high-risk prostate cancer patients treated with definitive radiation therapy

John Muir Health provides new cancer treatment using Varian's RapidArc radiation therapy

NephRx receives new U.S. patent for NX002 to treat oral mucositis

MnSOD oral drug can protect against lung cancer radiation therapy

SCCA, ProCure to open new proton therapy center for cancer treatment

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News